Literature DB >> 10198420

CCAAT/enhancer binding protein-beta trans-activates murine nitric oxide synthase 2 gene in an MTAL cell line.

A K Gupta1, B C Kone.   

Abstract

Nitric oxide production by nitric oxide synthase 2 (NOS2) has been implicated in epithelial cell injury from oxidative and immunologic stress. The NOS2 gene is transcriptionally activated by lipopolysaccharide (LPS) and cytokines in medullary thick ascending limb of Henle's loop (MTAL) cells and other cell types. The 5'-flanking region of the NOS2 gene contains a consensus element for CCAAT/enhancer binding proteins (C/EBP) at -150 to -142 that we hypothesized contributes to NOS2 trans-activation in the mouse MTAL cell line ST-1. Gel shift assays demonstrated LPS + interferon-gamma (IFN-gamma) induction of C/EBP family protein-DNA complexes in nuclei harvested from the cells. Supershift assays revealed that the complexes were comprised of C/EBPbeta, but not C/EBPalpha, C/EBPdelta, or C/EBPepsilon. NOS2 promoter-luciferase genes harboring deletion or mutation of the C/EBP box exhibited lower activities in response to LPS + IFN-gamma compared with wild-type NOS2 promoter constructs. Overexpression of a C/EBP-specific dominant-negative mutant limited LPS + IFN-gamma activation of the NOS2 promoter. In trans-activation assays, overexpression of C/EBPbeta stimulated basal NOS2 promoter activity. Thus C/EBPbeta appears to be an important trans-activator of the NOS2 gene in the MTAL.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198420     DOI: 10.1152/ajprenal.1999.276.4.F599

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells.

Authors:  M Jana; X Liu; S Koka; S Ghosh; T M Petro; K Pahan
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

2.  CD40 and tumour necrosis factor-α co-operate to up-regulate inducuble nitric oxide synthase expression in macrophages.

Authors:  Jose-Andres C Portillo; Luis Muniz Feliciano; Genevieve Okenka; Frederick Heinzel; M Cecilia Subauste; Carlos S Subauste
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

3.  Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.

Authors:  Puneet Dhawan; Xiaorong Peng; Amelia L M Sutton; Paul N MacDonald; Colleen M Croniger; Christian Trautwein; Michael Centrella; Thomas L McCarthy; Sylvia Christakos
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

4.  Kidney-specific activity of the bovine uromodulin promoter.

Authors:  Hun-Taek Kim; In-Young Song; Jorge Piedrahita
Journal:  Transgenic Res       Date:  2003-04       Impact factor: 2.788

Review 5.  Cell models for studying renal physiology.

Authors:  M Bens; A Vandewalle
Journal:  Pflugers Arch       Date:  2008-04-22       Impact factor: 3.657

6.  Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.

Authors:  Zhiyuan Yu; Wenzheng Zhang; Bruce C Kone
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

7.  Inducible nitric oxide synthase expression inhibition by adenovirus E1A.

Authors:  Wangsen Cao; Clare Bao; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

Review 8.  Small bowel review: Diseases of the small intestine.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.487

9.  TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanisms.

Authors:  Sarah A Benson; Joel D Ernst
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

10.  Modulation of inducible nitric oxide synthase expression by sumoylation.

Authors:  Candan A Akar; Douglas L Feinstein
Journal:  J Neuroinflammation       Date:  2009-03-26       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.